Endocannabinoids restrict hippocampal long-term potentiation via CB1

Area of Science:

• Neuroscience
• Molecular Biology
• Synaptic Plasticity

Background:

• Cannabinoid ligands affect cognition and synaptic plasticity.
• The role of endogenous cannabinoids (eCBs) in hippocampal long-term potentiation (LTP) is not fully understood.
• Previous research indicated cyclooxygenase-2 (COX-2) regulates eCB levels, impacting basal transmission.

Purpose of the Study:

• To investigate the influence of eCBs on LTP in the CA1 hippocampus.
• To determine the role of COX-2 in regulating eCBs and their effect on LTP.
• To elucidate the mechanism by which eCBs modulate synaptic plasticity.

Main Methods:

• Electrophysiological recordings of hippocampal slices.
• Application of CB1 receptor antagonists.
• Stimulation protocols including moderate, robust, and theta-burst stimulations.
• Pharmacological inhibition of cyclooxygenase-2 (COX-2) and other eCB degradation pathways.

Main Results:

• LTP induced by moderate stimulation (20 or 50 pulses) was enhanced by CB1 blockade.
• LTP induced by robust stimulation (100 or 200 pulses) was unaffected by CB1 blockade.
• CB1 blockade facilitated LTP induced by theta-burst stimulation, suggesting tonic inhibition by eCBs.
• Inhibition of COX-2 prevented theta-burst stimulation-induced LTP.
• Inhibition of COX-1 or other eCB degradation routes did not impact LTP.

Conclusions:

• Endogenous cannabinoids (eCBs) exert a tonic inhibitory influence on hippocampal LTP induction.
• Cyclooxygenase-2 (COX-2) plays a critical role in the formation of CB1 ligands that negatively regulate LTP.
• These findings clarify the role of eCBs in synaptic plasticity within the hippocampus.